4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Metaxalone.
Acepromazine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Aceprometazine.
Advertisement
Alfaxalone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Metaxalone.
Alphaprodine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Alphaprodine.
Advertisement
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Metaxalone.
Amisulpride
The risk or severity of adverse effects can be increased when Metaxalone is combined with Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Metaxalone.
Advertisement
Amobarbital
The risk or severity of adverse effects can be increased when Amobarbital is combined with Metaxalone.
Amoxapine
The risk or severity of adverse effects can be increased when Amoxapine is combined with Metaxalone.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Metaxalone.
Articaine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Asenapine is combined with Metaxalone.
Azelastine
Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Metaxalone.
Barbital
The risk or severity of adverse effects can be increased when Metaxalone is combined with Barbital.
Benoxinate
The risk or severity of adverse effects can be increased when Metaxalone is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Metaxalone is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Benzocaine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Metaxalone is combined with Benzyl alcohol.
Brexpiprazole
The risk or severity of adverse effects can be increased when Metaxalone is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Metaxalone.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Metaxalone.
Bromperidol
The risk or severity of adverse effects can be increased when Metaxalone is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Metaxalone is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Bupivacaine.
Buprenorphine
Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Buspirone is combined with Metaxalone.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Metaxalone.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Metaxalone.
Butamben
The risk or severity of adverse effects can be increased when Metaxalone is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Metaxalone is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Metaxalone.
Carbamazepine
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Metaxalone.
Carbinoxamine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Carbinoxamine.
Carisoprodol
The risk or severity of adverse effects can be increased when Carisoprodol is combined with Metaxalone.
Cetirizine
The risk or severity of adverse effects can be increased when Cetirizine is combined with Metaxalone.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Metaxalone is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Metaxalone.
Chlormethiazole
The risk or severity of adverse effects can be increased when Metaxalone is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Chloroprocaine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Metaxalone is combined with Chlorphenamine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Metaxalone.
Chlorprothixene
The risk or severity of adverse effects can be increased when Metaxalone is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Metaxalone.
Citalopram
The risk or severity of adverse effects can be increased when Metaxalone is combined with Citalopram.
Clemastine
The risk or severity of adverse effects can be increased when Clemastine is combined with Metaxalone.
Clidinium
The risk or severity of adverse effects can be increased when Metaxalone is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Metaxalone is combined with Clidinium.
Clobazam
The risk or severity of adverse effects can be increased when Clobazam is combined with Metaxalone.
Clomipramine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Metaxalone is combined with Clonazepam.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Metaxalone.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Metaxalone.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Metaxalone.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Metaxalone.
Cocaine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Metaxalone.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Metaxalone.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Metaxalone.
Cyclizine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Metaxalone.
Cyproheptadine
The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Metaxalone.
Dantrolene
The risk or severity of adverse effects can be increased when Metaxalone is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Metaxalone is combined with Dapiprazole.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Metaxalone.
Desipramine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Desloratadine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Desvenlafaxine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Metaxalone.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Dexmedetomidine.
Dextromoramide
The risk or severity of adverse effects can be increased when Metaxalone is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Metaxalone.
Dibucaine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Cinchocaine.
Difenoxin
The risk or severity of adverse effects can be increased when Metaxalone is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Metaxalone.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Metaxalone is combined with Dimenhydrinate.
Diphenhydramine
The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Metaxalone.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Metaxalone.
Doxepin
The risk or severity of adverse effects can be increased when Metaxalone is combined with Doxepin.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Metaxalone.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Metaxalone.
Duloxetine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Dyclonine.
Efavirenz
The risk or severity of adverse effects can be increased when Efavirenz is combined with Metaxalone.
Enflurane
The risk or severity of adverse effects can be increased when Metaxalone is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Entacapone is combined with Metaxalone.
Escitalopram
The risk or severity of adverse effects can be increased when Metaxalone is combined with Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Metaxalone.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Metaxalone.
Ethanol
Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Metaxalone is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Ethosuximide is combined with Metaxalone.
Ethotoin
The risk or severity of adverse effects can be increased when Metaxalone is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Metaxalone is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Metaxalone is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Metaxalone is combined with Etomidate.
Ezogabine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Metaxalone is combined with Felbamate.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Metaxalone.
Fexofenadine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Fexofenadine.
Flibanserin
The risk or severity of adverse effects can be increased when Metaxalone is combined with Flibanserin.
Flunarizine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Metaxalone is combined with Flunitrazepam.
Fluoxetine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Flupentixol is combined with Metaxalone.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Metaxalone.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Metaxalone.
Fluspirilene
The risk or severity of adverse effects can be increased when Metaxalone is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Metaxalone.
Fluvoxamine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Fluvoxamine.
Fosphenytoin
The risk or severity of adverse effects can be increased when Metaxalone is combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Metaxalone is combined with Fospropofol.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Metaxalone.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Metaxalone is combined with Gabapentin Enacarbil.
Glutethimide
The risk or severity of adverse effects can be increased when Metaxalone is combined with Glutethimide.
Guanfacine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Metaxalone is combined with Halazepam.
Haloperidol
The risk or severity of adverse effects can be increased when Haloperidol is combined with Metaxalone.
Halothane
The risk or severity of adverse effects can be increased when Metaxalone is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Metaxalone is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Metaxalone is combined with Hexobarbital.
Hydrocodone
Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Metaxalone.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Metaxalone.
Iloperidone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Iloperidone.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Metaxalone.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Metaxalone.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Metaxalone.
Ketazolam
The risk or severity of adverse effects can be increased when Metaxalone is combined with Ketazolam.
Lamotrigine
The risk or severity of adverse effects can be increased when Lamotrigine is combined with Metaxalone.
Levetiracetam
The risk or severity of adverse effects can be increased when Metaxalone is combined with Levetiracetam.
Levobupivacaine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Levocetirizine.
Levodopa
The risk or severity of adverse effects can be increased when Metaxalone is combined with Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Metaxalone is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Metaxalone is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Metaxalone.
Lidocaine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Lidocaine.
Lithium
The risk or severity of adverse effects can be increased when Metaxalone is combined with Lithium.
Lithium Cation
The risk or severity of adverse effects can be increased when Metaxalone is combined with Lithium.
Loratadine
The risk or severity of adverse effects can be increased when Loratadine is combined with Metaxalone.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Metaxalone.
Lormetazepam
The risk or severity of adverse effects can be increased when Metaxalone is combined with Lormetazepam.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Metaxalone.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Metaxalone.
Magnesium Sulfate
The therapeutic efficacy of Metaxalone can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Metaxalone can be increased when used in combination with Magnesium sulfate.
Maprotiline
The risk or severity of adverse effects can be increased when Metaxalone is combined with Maprotiline.
Meclizine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Meclizine.
Melatonin
The risk or severity of adverse effects can be increased when Metaxalone is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Metaxalone.
Mephobarbital
The risk or severity of adverse effects can be increased when Metaxalone is combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Metaxalone.
Mesoridazine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Mesoridazine.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Metaxalone.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Metaxalone is combined with Methadyl Acetate.
Methapyrilene
The risk or severity of adverse effects can be increased when Metaxalone is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Methocarbamol is combined with Metaxalone.
Methohexital
The risk or severity of adverse effects can be increased when Methohexital is combined with Metaxalone.
Methotrimeprazine
Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Metaxalone is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Metaxalone is combined with Methsuximide.
Metylperon
The risk or severity of adverse effects can be increased when Metaxalone is combined with Melperone.
Metyrosine
Metaxalone may increase the sedative activities of Metyrosine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Metaxalone.
Milnacipran
The risk or severity of adverse effects can be increased when Metaxalone is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Metaxalone.
Mirtazapine
Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Molindone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Metaxalone.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Metaxalone.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Metaxalone.
Nefazodone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Nefazodone.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Metaxalone.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Metaxalone.
Norflurane
The risk or severity of adverse effects can be increased when Metaxalone is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Nortriptyline is combined with Metaxalone.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Metaxalone.
Olopatadine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Olopatadine.
Ondansetron
The risk or severity of adverse effects can be increased when Metaxalone is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Metaxalone is combined with Opium.
Orphenadrine
Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Metaxalone.
Oxprenolol
The risk or severity of adverse effects can be increased when Metaxalone is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Metaxalone.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Metaxalone.
Paliperidone
The risk or severity of adverse effects can be increased when Paliperidone is combined with Metaxalone.
Paraldehyde
Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Metaxalone.
Paroxetine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Paroxetine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Metaxalone.
Pentobarbital
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Metaxalone.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Metaxalone.
Perazine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Perazine.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Metaxalone.
Phenobarbital
The risk or severity of adverse effects can be increased when Phenobarbital is combined with Metaxalone.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Metaxalone is combined with Phenoxyethanol.
Phenytoin
The risk or severity of adverse effects can be increased when Phenytoin is combined with Metaxalone.
Pimozide
The risk or severity of adverse effects can be increased when Pimozide is combined with Metaxalone.
Pipamperone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Pipotiazine.
Pirinitramide
The risk or severity of adverse effects can be increased when Metaxalone is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Metaxalone is combined with Pizotifen.
Pomalidomide
The risk or severity of adverse effects can be increased when Metaxalone is combined with Pomalidomide.
Pramipexole
Metaxalone may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Metaxalone is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Metaxalone can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Prilocaine.
Primidone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Primidone.
Procaine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Procaine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Metaxalone.
Promazine
The risk or severity of adverse effects can be increased when Promazine is combined with Metaxalone.
Promethazine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Promethazine.
Proparacaine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Metaxalone.
Propoxyphene
The risk or severity of adverse effects can be increased when Metaxalone is combined with Dextropropoxyphene.
Protriptyline
The risk or severity of adverse effects can be increased when Protriptyline is combined with Metaxalone.
Quazepam
The risk or severity of adverse effects can be increased when Quazepam is combined with Metaxalone.
Quetiapine
The risk or severity of adverse effects can be increased when Quetiapine is combined with Metaxalone.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Quetiapine is combined with Metaxalone.
Ramelteon
The risk or severity of adverse effects can be increased when Metaxalone is combined with Ramelteon.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Metaxalone.
Remoxipride
The risk or severity of adverse effects can be increased when Metaxalone is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Metaxalone.
Risperidone
The risk or severity of adverse effects can be increased when Risperidone is combined with Metaxalone.
Ropinirole
Metaxalone may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Ropivacaine.
Rotigotine
Metaxalone may increase the sedative activities of Rotigotine.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Metaxalone.
Scopolamine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Scopolamine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Metaxalone is combined with Scopolamine.
Secobarbital
The risk or severity of adverse effects can be increased when Secobarbital is combined with Metaxalone.
Sertindole
The risk or severity of adverse effects can be increased when Metaxalone is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Metaxalone is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Metaxalone.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Metaxalone.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Metaxalone.
Sulpiride
The risk or severity of adverse effects can be increased when Metaxalone is combined with Sulpiride.
Suvorexant
Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Metaxalone.
Tasimelteon
The risk or severity of adverse effects can be increased when Metaxalone is combined with Tasimelteon.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Metaxalone.
Tetrabenazine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Metaxalone is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Metaxalone.
Thalidomide
Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
The risk or severity of adverse effects can be increased when Metaxalone is combined with Thiamylal.
Thiopental
The risk or severity of adverse effects can be increased when Metaxalone is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Metaxalone is combined with Thiopental.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Metaxalone.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Metaxalone.
Tiagabine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Tiagabine.
Tiapride
The risk or severity of adverse effects can be increased when Metaxalone is combined with Tiapride.
Tizanidine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Tizanidine.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Metaxalone.
Topiramate
The risk or severity of adverse effects can be increased when Topiramate is combined with Metaxalone.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Metaxalone.
Tranylcypromine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Trazodone.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Metaxalone.
Triazulenone
The risk or severity of adverse effects can be increased when Metaxalone is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Metaxalone.
Triflupromazine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Triflupromazine.
Trimipramine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Trimipramine.
Triprolidine
The risk or severity of adverse effects can be increased when Triprolidine is combined with Metaxalone.
Urethane
The risk or severity of adverse effects can be increased when Metaxalone is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Metaxalone is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Metaxalone is combined with Valproic Acid.
Venlafaxine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Venlafaxine.
Vigabatrin
The risk or severity of adverse effects can be increased when Metaxalone is combined with Vigabatrin.
Vortioxetine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Vortioxetine.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Metaxalone.
Ziconotide
The risk or severity of adverse effects can be increased when Metaxalone is combined with Ziconotide.
Ziprasidone
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Metaxalone.
Zolpidem
Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Metaxalone is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Metaxalone.
Zotepine
The risk or severity of adverse effects can be increased when Metaxalone is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Metaxalone.
